Cellectis S.A. current report, Q2 FY2019

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K, filed on May 3, 2019, by Cellectis S.A., a foreign private issuer based in Paris, France, serves as a notice regarding an upcoming corporate governance event. The filing does not contain financial results or operational updates for a specific reporting period.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a procedural notice and contains no financial data.

Material Changes

No material changes to financial performance or operations are reported in this filing. The document solely announces the scheduling of a shareholder meeting.

Guidance, Outlook, and Management Commentary

Management has announced the Combined Ordinary and Extraordinary General Meeting to be held on June 25, 2019, at 9:30 a.m. (Paris time). The meeting will take place at the company's principal executive office at 8, rue de la Croix Jarry, 75013 Paris, France. The Notice of the Meeting, including the Agenda, is attached as Exhibit 99.1.

Key Facts for Investor Verification

  • Meeting Date: June 25, 2019.
  • Meeting Time: 9:30 a.m. Paris time.
  • Meeting Location: 8, rue de la Croix Jarry, 4th floor, 75013 Paris, France.
  • Document Reference: Notice of Combined Shareholders' Meeting (Exhibit 99.1) contains the full agenda.
  • Financial Data: None included in this specific filing.